Tvardi Therapeutics, Inc. (TVRD) — 8-K/A Filings

All 8-K/A filings from Tvardi Therapeutics, Inc.. Browse 2 Amended Current Event Report reports with AI-powered summaries and risk analysis.

8-K/A Filings (2)

  • Tvardi Therapeutics Files 8-K/A Amendment — May 13, 2025 Risk: low
    Tvardi Therapeutics, Inc. filed an amendment (8-K/A) on May 13, 2025, to a previous filing concerning the completion of an acquisition or disposition of assets.
  • Cara Therapeutics Files 8-K/A Amendment — Dec 20, 2024 Risk: low
    Cara Therapeutics, Inc. filed an 8-K/A on December 20, 2024, to amend a previous filing. The amendment pertains to Item 9.01, Financial Statements and Exhibits,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.